Phase 2 N=18 Randomized Treatment

Treatment of Dysphagia Using the Mendelsohn Maneuver

Stroke · Dysphagia

Bottom Line

View on ClinicalTrials.gov: NCT00592761 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2010

Primary outcome: Primary: Change in Duration of Superior Hyolaryngeal Movement — .213; .233 seconds

Study Design & Population

Study type: Interventional
Phase: Phase 2
Interventions: Mendelsohn Maneuver (Behavioral)
Age: Adult, Older Adult · 21+ yrs
Sex: All
Sponsor: University of Arkansas
Primary completion: Sep 2008

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Duration of Superior Hyolaryngeal Movement	.213; .233	—
PRIMARY Change in Duration of Hyoid Maximum Anterior Excursion	.233; .247	—
SECONDARY Change in Oral Intake Ability	1.8; 2.3	—
SECONDARY Change in Duration of Opening of Upper Esophageal Sphincter	.584; .610	—

Summary

The primary goal of the investigation is to determine the effects of the Mendelsohn maneuver on the physiology of the swallow in individuals who have suffered a stroke and exhibit signs of pharyngeal dysphagia.

Eligibility Criteria

Inclusion Criteria

Stroke (1-18 months post)
Pharyngeal Dysphagia

Exclusion Criteria

Other neurologic or structural abnormality to oropharynx
History of dysphagia prior to latest stroke

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00592761). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.